The FDA has issued warning letters to a Florida cheese manufacturer and a Minnesota seafood importer after inspections turned up cockroaches on cheese equipment and flies on ready-to-eat products, alongside repeated failures to verify that imported seafood met U.S. processing requirements.

The letters cap an enforcement process the agency runs on a fixed clock. Companies have 15 days to respond to an FDA warning letter, and the agency typically does not send one until a business has had months — in some cases years — to correct problems identified in earlier inspections.

The postings themselves often lag the enforcement action. The FDA does not always release warning letters for public view until weeks or months after it sends them, and portions of the letters are routinely redacted before publication.

What did inspectors find?

At the Florida cheese plant, inspectors documented recurring sanitation failures. The findings included:

• Cockroaches on cheese production equipment;
• Flies on ready-to-eat products.

Ready-to-eat items carry elevated risk because consumers eat them without a pathogen-reduction step, making post-process contamination a direct food safety hazard rather than a quality issue.

At the Minnesota importer, the violation was procedural: repeated failures to verify that the seafood it brought into the U.S. was processed in compliance with American requirements. Importers act as the gatekeeper for foreign suppliers under FDA rules, so an unverified supply chain shifts compliance risk onto the domestic entity holding the warning letter.

What happens next?

Both companies now face the standard warning-letter timeline: a 15-day response window in which management must lay out corrective actions, or risk escalation. The FDA treats warning letters as formal notice that continued violations can trigger seizure, injunction or import refusal.

Neither the cheese manufacturer nor the seafood importer is named in the publicly released summary beyond its state and product category, a function of the agency's routine redaction of letter portions before posting.

The next measurable signal for both firms will be whether follow-up inspections confirm the sanitation lapses and importer verification gaps have closed — or whether the FDA moves from warning letter to enforcement action.